MedTrace Logo

Molecular and Morphologic Characterization of Circulating Endothelial Cells

NCT01005485 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 664

Last updated 2025-01-17

No results posted yet for this study

Summary

The primary hypothesis of this study is that circulating endothelial cells (CECs) harbor key genetic and structural characteristics predisposing individuals to acute atherosclerotic plaque rupture and heart attack.

Conditions

  • Acute Myocardial Infarction

Sponsors & Collaborators

  • Scripps Translational Science Institute

    lead OTHER

Principal Investigators

  • Eric Topol, M.D. · Scripps Translational Science Institute

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2017-04-30
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01005485 on ClinicalTrials.gov